New York, Global Benign Prostatic Hyperplasic Devices Market from Global Insight Services is the only authoritative source for intelligence on the Benign Prostatic Hyperplasic Devices Market . The report will provide you with an analysis of the impact of the latest market disruptions such as the Russo-Ukrainian War and Covid-19 on the market. The report provides a qualitative analysis of the market using various frameworks such as Porters Analysis and PESTLE. The report includes in-depth segmentation and market size data by categories, product types, applications, and geographic regions. The report also includes a comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as mergers and acquisitions activities in the market.
Request sample copy of this research study:https://www.globalinsightservices.com/request-sample/GIS10422/
The global benign Prostatic hyperplasic devices market was valued at USD 2078.0 million in 2021 and it is anticipated to grow further till USD 4317.5 million by 2031, at a CAGR of 7.6% during the forecast period.
Benign prostatic hyperplasia is a non-cancerous (benign) endocrine growth that may make urination difficult. Men get benign prostatic hyperplasia (BPH) more frequently as they age, especially after the age of 50. Although the exact reason is unknown, hormone changes, particularly those brought on by dihydrotestosterone and testosterone, are most likely to be to blame. BPH is a Prostatic enlargement that affects 110 million men worldwide. Prostatic adenoma cells produce extra tissue, which can lead to symptoms that have an adverse effect on a patient’s quality of life, such as a constant, urgent need to urinate.
Free customization available –https://www.globalinsightservices.com/request-customization/GIS10422
Market Trends and Drivers
The ageing population, rising demand for minimally invasive treatments, and ongoing technological improvements have all contributed to the creation of BPH devices of the highest possible quality and safety. Furthermore, the development of less invasive BPH methods with improved safety and efficacy has been aided by technology improvements.
Men’s Prostatics may grow with age and limit or stop urine flow. The National Institute on Aging reports that the global geriatric population was 8.5% in 2015 and is projected to increase to 17% by 2050. These statistics demonstrate the increasing demand for home infusion therapy among a population that is at high risk. 90% of men in their 70s and 80s, as well as more than half of all men in their 60s.
Major Players in the Global Benign Prostatic Hyperplasic Devices Market
The key players studied in the report are Endo International plc, KARL STORZ GMBH & CO.KG, Lumenis, Olympus corporation, Urologix, Inc., Boston Scientific corporation, Coloplast A/S, Lisa Laser, Medifocus, Inc., Neotract, Inc., ProArc Medical LTD., and Urotech GMBH among others.
Purchase This Market Research Report – https://www.globalinsightservices.com/checkout/single_user/GIS10422
With Global Insight Services, you receive:
- 10-year forecasts to help you make strategic decisions
- In-depth segmentation that can be customized according to your requirements
- Free consultation with the lead analyst of the report
- Excel data package included with all report purchases
- Robust and transparent research methodology
Leading research and solutions centered around the market player for the next decade according to the current market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700